Real World Evidence (RWE)
Real world data (RWD) refers to health data that can be used, for example, to demonstrate the value of a certain treatment or technology for patients, healthcare service providers or society (RWE). Due to comprehensive healthcare, data in digital format, a personal ID, and progressive research legislation, Finland is a true model country for Real World Evidence studies.
Medaffcon has the most extensive experience in analyzing and utilizing real world data (RWD) in Finland. We have been conducting RWE studies since 2013 when the Biobank Act came into effect and allowed for more extensive use of the data when conducting research. Our RWE-studies are closely related to the health economics perspective on the cost-effectiveness of interventions. Also, we are closely involved in supporting and developing unique information sources in Finland.
We provide individually tailored RWE research services to different healthcare actors, where our scientific experts and bioinformatics ensure that the correct research methods and data sources are used to answer your questions.
Medaffcon’s RWE studies have gathered new knowledge in different therapeutic areas, including:
- Disease burden of different patient groups
- Use of healthcare resources
- Diagnostics of rare diseases
- Treatment lines and outcomes
- Characteristics of patient subgroups
- Outlining regional treatment practices
Read more about our publications
More information on RWE-studies and the opportunities they can bring to us can be found on our Future Care Finland website